Literature DB >> 25796340

Depressive symptomatology and respiratory sinus arrhythmia in a non-clinical sample of middle-aged African Americans.

Larry Keen1, Arlener D Turner2, Denee Mwendwa3, Clive Callender4, Alfonso Campbell5.   

Abstract

Decreased heart rate variability and depression are both independent risk factors for cardiac mortality in clinical and non-clinical samples. The purpose of the current study is to examine the hypothesis that severity of depressive symptomatology is inversely associated with respiratory sinus arrhythmia (RSA) in a non-clinical sample of African Americans. The sample included 77 African Americans with a mean age of 48.4 (SD = 11.7). Participants completed the Beck Depression Inventory-II (BDI-II) and a 5-min resting baseline measurement of RSA was collected. The BDI-II total score was positively associated with RSA (β = .334, p = .008). Given the unexpected direction of the association, we separated the BDI-II into cognitive and somatic affective subscales to identify which construct was driving the relationship. The somatic affective, was related to RSA (β = .328, p = .010), but not the cognitive subscale. Given this unexpected positive result, future research should further examine the nature of the relationship between depressive symptomatology and RSA in African Americans, as the relationship may vary based on levels of depressive symptomatology.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive; Depression; Depressive symptomatology; Heart rate variability; Respiratory sinus arrhythmia; Somatic affective

Mesh:

Year:  2015        PMID: 25796340      PMCID: PMC4426063          DOI: 10.1016/j.biopsycho.2015.03.008

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  47 in total

Review 1.  Cultural variations in the clinical presentation of depression and anxiety: implications for diagnosis and treatment.

Authors:  L J Kirmayer
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

2.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

3.  Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.

Authors:  R C Arnau; M W Meagher; M P Norris; R Bramson
Journal:  Health Psychol       Date:  2001-03       Impact factor: 4.267

Review 4.  The role of vagal function in the risk for cardiovascular disease and mortality.

Authors:  Julian F Thayer; Richard D Lane
Journal:  Biol Psychol       Date:  2006-12-19       Impact factor: 3.251

5.  The importance of somatic symptoms in depression in primary care.

Authors:  André Tylee; Paul Gandhi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

6.  Depression, heart rate variability, and acute myocardial infarction.

Authors:  R M Carney; J A Blumenthal; P K Stein; L Watkins; D Catellier; L F Berkman; S M Czajkowski; C O'Connor; P H Stone; K E Freedland
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

7.  Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.

Authors:  Alexander H Glassman; J Thomas Bigger; Michael Gaffney; Louis T Van Zyl
Journal:  Arch Gen Psychiatry       Date:  2007-09

8.  Heart period variability and depressive symptoms: gender differences.

Authors:  J F Thayer; M Smith; L A Rossy; J J Sollers; B H Friedman
Journal:  Biol Psychiatry       Date:  1998-08-15       Impact factor: 13.382

9.  Preadolescents' somatic and cognitive-affective depressive symptoms are differentially related to cardiac autonomic function and cortisol: the TRAILS study.

Authors:  Nienke M Bosch; Harriëtte Riese; Andrea Dietrich; Johan Ormel; Frank C Verhulst; Albertine J Oldehinkel
Journal:  Psychosom Med       Date:  2009-10-15       Impact factor: 4.312

10.  Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction.

Authors:  Heikki V Huikuri; M J Pekka Raatikainen; Rikke Moerch-Joergensen; Juha Hartikainen; Vesa Virtanen; Jean Boland; Olli Anttonen; Nis Hoest; Lucas V A Boersma; Eivind S Platou; Marc D Messier; Poul-Erik Bloch-Thomsen
Journal:  Eur Heart J       Date:  2009-01-20       Impact factor: 29.983

View more
  6 in total

1.  Examining the association between perceived discrimination and heart rate variability in African Americans.

Authors:  LaBarron K Hill; Lori S Hoggard; Ashley S Richmond; DeLeon L Gray; Dewayne P Williams; Julian F Thayer
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2017-01

2.  Racial differences in the association between heart rate variability and left ventricular mass.

Authors:  LaBarron K Hill; Lana L Watkins; Alan L Hinderliter; James A Blumenthal; Andrew Sherwood
Journal:  Exp Physiol       Date:  2017-05-26       Impact factor: 2.969

3.  Active coping moderates associations among race-related stress, rumination, and depressive symptoms in emerging adult African American women.

Authors:  Labarron K Hill; Lori S Hoggard
Journal:  Dev Psychopathol       Date:  2018-12

Review 4.  Guidelines for Reporting Articles on Psychiatry and Heart rate variability (GRAPH): recommendations to advance research communication.

Authors:  D S Quintana; G A Alvares; J A J Heathers
Journal:  Transl Psychiatry       Date:  2016-05-10       Impact factor: 6.222

5.  Association Between Depression, Anxiety, and Antidepressant Use With T-Wave Amplitude and QT-Interval.

Authors:  Mandy X Hu; Femke Lamers; Brenda W J H Penninx; Eco J C de Geus
Journal:  Front Neurosci       Date:  2018-06-05       Impact factor: 4.677

6.  Cardiac Vagal Control, Regulatory Processes and Depressive Symptoms: Re-Investigating the Moderating Role of Sleep Quality.

Authors:  Sarah K Danböck; Gabriela G Werner
Journal:  Int J Environ Res Public Health       Date:  2019-10-23       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.